Literature DB >> 2913807

Pseudoglaucomatous physiologic large cups.

J B Jonas1, F M Zäch, G C Gusek, G O Naumann.   

Abstract

Using planimetric analysis of stereoscopic optic disk photographs, we studied 21 optic nerve heads of 11 subjects who shared the common feature of optic cups that were larger than the mean + 2 S.D. within the normal population. A comparison of these findings to those of 571 normal optic disks and 706 optic nerve heads in eyes with chronic primary open-angle glaucoma showed the following morphologic characteristics: (1) abnormally large optic disk area (mean +/- S.D., 4.49 +/- 0.56 mm2), (2) large cup/disk ratios with the horizontal ratio (0.78 +/- 0.03) significantly (P less than .001) larger that the vertical (0.71 +/- 0.03), (3) increased incidence of cilioretinal arteries, (4) normal neuroretinal rim area (2.06 +/- 0.35 mm2), (5) normal neuroretinal rim configuration, inferiorly (0.43 +/- 0.08 mm) broader (P less than .001, Wilcoxon test) than superiorly (0.33 +/- 0.06 mm), smallest (P less than .0001) temporally (0.20 +/- 0.04 mm), (6) normal form of zone alpha (irregular hypopigmentation and hyperpigmentation) of the parapapillary chorioretinal atrophy with its widest extension in the temporal horizontal area, (7) no zone beta (visible large choroidal vessels and sclera), (8) normal caliber of the parapapillary retinal vessels, and (9) normal parapillary retinal nerve fiber layer. These characteristics are helpful in the differentiation of primary and secondary large cups.

Entities:  

Mesh:

Year:  1989        PMID: 2913807     DOI: 10.1016/0002-9394(89)90212-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Intra- and inter-observer variation of optic nerve head measurements in glaucoma suspects using disc-data.

Authors:  J Stürmer; D Poinoosawmy; D C Broadway; R A Hitchings
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

2.  Intraocular pressure in patients with Cushing's disease.

Authors:  J B Jonas; O Huschle; G Koniszewski; M Buchfelder; R Fahlbusch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Disc damage likelihood scale.

Authors:  J D Henderer
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

4.  Optic disc morphology in myopic primary open-angle glaucoma.

Authors:  J B Jonas; A Dichtl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

5.  Histomorphometry of the optic disc in highly myopic eyes with absolute secondary angle closure glaucoma.

Authors:  A Dichtl; J B Jonas; G O Naumann
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 6.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

7.  Dark adaptation in glaucomatous and nonglaucomatous optic nerve atrophy.

Authors:  J B Jonas; F M Zäch; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

8.  Determination of the neuroretinal rim area using the horizontal and vertical disc and cup diameters.

Authors:  J B Jonas; D M Montgomery
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

9.  Comparison between central corneal thickness and IOP in patients with macrodiscs with physiologic macrocup and normal-sized vital discs.

Authors:  Arne Viestenz; Nina Wakili; Anselm G M Jünemann; Folkert K Horn; Christian Y Mardin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-25       Impact factor: 3.117

10.  Comparison of disc damage likelihood scale, cup to disc ratio, and Heidelberg retina tomograph in the diagnosis of glaucoma.

Authors:  H V Danesh-Meyer; B J Gaskin; T Jayusundera; M Donaldson; G D Gamble
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.